?
z.B. 0-20
?
z.B. 0-15
?
z.B. 0-5
?
z.B. 0-3
Die Kennzahlen-Filter werden aktiviert, sobald die vollständige Liste geladen ist.
518 Unternehmen gefunden • Seite 7 von 21
? | ? | ? | ? | ? | ? | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() | Yunnan Baiyao Group Co Ltd | 57.7 | Arzneimittel (Pharmazeutisch) | China | 13.4 Mrd. USD | 17.22 | 422.36 | 2.15 | 2.19 | ▲ 4.70% | ▼ -1.35% | 3.14% | ▼ -10.69% | - | 12.51% | ▲ 1.32% | 12.21% | ▲ 1.03% | 10.00% | ▼ -0.43% | 7 / 9 | 7,39 | > 50-fach | 22 / 100 | 1,0 / 100 | −3,13 |
![]() | Amphastar P | 57.3 | Arzneimittel (Pharmazeutisch) | USA | 1.0 Mrd. USD | 12.88 | 6.62 | 1.39 | 1.32 | ▲ 15.53% | ▲ 133.84% | - | - | - | 13.63% | ▲ 0.24% | 19.50% | ▲ 1.36% | 16.84% | ▲ 1.19% | 6 / 9 | 4,86 | 7-fach | 22 / 100 | −3,6 / 100 | −2,70 |
![]() | Alvotech | 57.3 | Arzneimittel (Biotechnologie) | Luxemburg | 1.9 Mrd. USD | - | - | 3.84 | -9.86 | ▲ 54.49% | - | - | - | - | 4.76% | ▲ 113.28% | 13.34% | ▲ 173.88% | -19.56% | ▲ 179.81% | 3 / 9 | −2,97 | −0,7-fach | 24 / 100 | 5,3 / 100 | −2,54 |
![]() | Alnylam Pharmaceuticals Inc | 56.6 | Arzneimittel (Biotechnologie) | USA | 33.3 Mrd. USD | 41.18 | 61.33 | 6.93 | 24.57 | ▲ 49.77% | - | - | - | - | 8.45% | ▲ 31.56% | 13.51% | ▲ 26.27% | 12.53% | ▲ 25.24% | 6 / 9 | −0,01 | 0-fach | 61 / 100 | −4,2 / 100 | −2,01 |
| Shanghai RAAS Blood Products Co Ltd Class A | 56.0 | Arzneimittel (Biotechnologie) | China | 4.8 Mrd. USD | 26.68 | - | 4.88 | 0.99 | ▲ 21.62% | ▲ 3.56% | 1.66% | - | - | 21.46% | ▼ -1.93% | 26.05% | ▼ -2.23% | -6.59% | ▼ -9.77% | 3 / 9 | 8,94 | > 50-fach | 7 / 100 | 4,5 / 100 | −2,06 | |
| Shanghai Haohai Biological | 55.2 | Arzneimittel (Biotechnologie) | China | 0.5 Mrd. USD | 21.77 | 12.14 | 1.36 | 0.60 | ▲ 13.06% | ▲ 1.76% | 5.93% | ▼ -7.76% | - | 10.26% | ▼ -1.26% | 9.06% | ▲ 0.36% | 18.25% | ▲ 4.31% | 4 / 9 | 9,37 | 29-fach | 26 / 100 | −5,8 / 100 | −3,12 | |
| Shanghai Haohai Biological Tech Co | 55.0 | Arzneimittel (Biotechnologie) | China | 1.0 Mrd. USD | 25.81 | 15.30 | 2.62 | 1.19 | ▲ 13.30% | ▲ 1.76% | 3.46% | - | - | 10.15% | ▼ -1.28% | 8.92% | ▲ 0.33% | 12.29% | ▲ 3.12% | 6 / 9 | 9,37 | 28-fach | 26 / 100 | −3,7 / 100 | −3,36 | |
| Collegium Pharmaceutical Inc | 54.6 | Arzneimittel (Pharmazeutisch) | USA | 0.7 Mrd. USD | 14.72 | 2.15 | 0.87 | 2.26 | ▲ 20.28% | ▲ 18.64% | - | - | - | 8.05% | ▼ -1.92% | 23.97% | ▲ 5.49% | 41.97% | ▲ 1.63% | 6 / 9 | 1,74 | 2-fach | 28 / 100 | −16,1 / 100 | −3,34 | |
| Shanghai Haixin Group Co Ltd A | 54.5 | Arzneimittel (Pharmazeutisch) | China | 1.5 Mrd. USD | 50.95 | - | 14.46 | 2.00 | ▼ -4.08% | ▲ 8.07% | 0.60% | ▲ 8.45% | 1 Jahre | 23.23% | ▲ 3.66% | 5.97% | ▲ 0.37% | 0.08% | ▼ -1.71% | 7 / 9 | 7,48 | > 50-fach | 8 / 100 | 1,0 / 100 | −3,25 | |
| Shanghai Haoyuan Chemexpress Co. Ltd. A | 54.1 | Arzneimittel (Pharmazeutisch) | China | 2.8 Mrd. USD | 69.65 | - | 5.81 | 5.62 | ▲ 35.19% | ▲ 14.04% | 0.24% | - | 1 Jahre | 8.64% | ▼ -2.75% | 10.81% | ▼ -2.57% | 3.35% | ▲ 11.80% | 8 / 9 | 4,30 | 5-fach | 18 / 100 | −3,3 / 100 | −2,40 | |
| Sinopep-Allsino Biopharmaceutical Co. Ltd. A | 54.0 | Arzneimittel (Biotechnologie) | China | 1.3 Mrd. USD | 38.28 | - | 4.37 | 2.87 | ▲ 27.93% | ▲ 21.51% | 1.25% | - | - | 16.83% | ▲ 0.29% | 20.59% | ▲ 0.97% | -35.30% | ▼ -3.39% | 6 / 9 | 1,99 | 9-fach | 29 / 100 | −5,3 / 100 | −2,93 | |
| China Grand Pharmaceutical and Healthcare Holdings Ltd | 53.5 | Arzneimittel (Pharmazeutisch) | Hong Kong | 2.1 Mrd. USD | 14.63 | 17.07 | 1.32 | 0.96 | ▲ 14.10% | ▼ -7.09% | 3.57% | ▲ 8.97% | - | 10.10% | ▼ -3.62% | 8.49% | ▼ -3.77% | 6.30% | ▼ -1.11% | 5 / 9 | 3,72 | 13-fach | 25 / 100 | −1,0 / 100 | −1,83 | |
![]() | Corcept Therapeutics Incorporated | 53.5 | Arzneimittel (Pharmazeutisch) | USA | 12.2 Mrd. USD | 222.10 | 114.03 | 14.68 | 17.28 | ▲ 16.56% | ▼ -1.23% | - | - | - | 13.09% | ▼ -3.98% | 5.88% | ▼ -6.40% | 18.62% | ▼ -5.51% | 4 / 9 | 9,15 | unbegrenzt | 89 / 100 | −5,1 / 100 | −2,87 |
![]() | Kalbe Farma Tbk PT | 53.3 | Arzneimittel (Pharmazeutisch) | Indonesien | 3.3 Mrd. USD | 9.21 | 13.55 | 0.88 | 1.37 | ▲ 8.85% | ▲ 6.04% | 2.72% | ▼ -6.51% | - | 10.38% | ▼ -0.53% | 12.87% | ▼ -0.90% | 6.97% | ▲ 0.08% | 6 / 9 | 10,93 | > 50-fach | 48 / 100 | 1,4 / 100 | −2,51 |
| Asymchem Laboratories Tian Jin Co Ltd | 53.0 | Arzneimittel (Pharmazeutisch) | China | 8.8 Mrd. USD | 57.16 | - | 8.35 | 3.34 | ▲ 16.29% | ▲ 9.49% | 0.79% | - | - | 16.98% | ▼ -2.81% | 18.80% | ▼ -2.03% | 2.06% | ▲ 6.19% | 7 / 9 | 11,97 | > 50-fach | 14 / 100 | −1,4 / 100 | −2,46 | |
| Nippon Shinyaku Co Ltd ADR | 53.0 | Arzneimittel (Pharmazeutisch) | Japan | 1.6 Mrd. USD | 7.43 | 12.34 | 1.30 | 0.81 | ▲ 8.24% | ▲ 8.77% | 3.40% | ▼ -64.65% | - | 17.40% | ▲ 0.30% | 19.34% | ▼ -0.71% | 14.19% | ▲ 2.08% | 5 / 9 | 11,37 | > 50-fach | 35 / 100 | 0,8 / 100 | −2,39 | |
![]() | Merck KGaA | 52.9 | Arzneimittel (Pharmazeutisch) | Deutschland | 66.2 Mrd. USD | 24.10 | 21.63 | 2.70 | 1.89 | ▲ 3.77% | ▲ 5.59% | 1.67% | ▲ 9.46% | - | 12.36% | ▼ -0.82% | 19.26% | ▼ -0.68% | 11.13% | ▼ -0.99% | 6 / 9 | 3,78 | 15-fach | 23 / 100 | −2,5 / 100 | −2,88 |
![]() | Pfizer Inc | 52.6 | Arzneimittel (Pharmazeutisch) | USA | 158.0 Mrd. USD | 36.45 | 14.38 | 2.48 | 1.85 | ▲ 8.48% | ▼ -4.17% | 6.20% | ▲ 1.97% | 15 Jahre | 12.42% | ▼ -4.83% | 24.67% | ▼ -1.33% | 14.50% | ▼ -5.50% | 7 / 9 | 3,06 | 3-fach | 21 / 100 | −1,9 / 100 | −2,55 |
| Chengdu Kanghua Biological Products | 52.0 | Arzneimittel (Biotechnologie) | China | 0.9 Mrd. USD | 25.65 | 148.68 | 5.19 | 1.75 | ▲ 2.32% | ▼ -11.63% | 1.03% | ▼ -5.59% | - | 18.88% | ▼ -10.41% | 23.44% | ▼ -10.96% | 26.52% | ▲ 12.70% | 6 / 9 | 13,73 | > 50-fach | 27 / 100 | −4,0 / 100 | −3,49 | |
![]() | GSK plc | 51.8 | Arzneimittel (Pharmazeutisch) | Vereinigtes Königreich - UK | 95.9 Mrd. USD | 14.71 | 12.32 | 2.14 | 4.02 | ▼ -0.85% | ▼ -0.12% | 3.83% | ▼ -2.40% | 2 Jahre | 17.50% | ▼ -4.33% | 21.95% | ▼ -0.46% | 18.23% | ▼ -1.04% | 9 / 9 | 1,39 | 9-fach | 39 / 100 | −2,6 / 100 | −2,43 |
![]() | Eton Pharmaceuticals Inc | 51.6 | Arzneimittel (Pharmazeutisch) | USA | 1.6 Mrd. USD | 128.59 | 110.82 | 15.45 | 35.02 | ▲ 359.57% | ▼ -30.30% | - | - | - | -5.75% | ▲ 3.90% | 0.09% | ▲ 4.61% | 12.75% | ▲ 9.14% | 4 / 9 | −1,98 | −0,2-fach | 46 / 100 | −16,4 / 100 | −2,45 |
| Joinn Laboratories China Co Ltd | 51.3 | Arzneimittel (Biotechnologie) | China | 2.0 Mrd. USD | 13.56 | 39.49 | 8.04 | 1.51 | ▲ 9.03% | ▼ -1.11% | 0.65% | ▼ -8.44% | - | 17.97% | ▼ -8.13% | 20.39% | ▼ -9.29% | 18.16% | ▼ -5.01% | 7 / 9 | 10,26 | > 50-fach | 4 / 100 | −1,5 / 100 | −2,39 | |
![]() | Shijiazhuang Yiling Pharmaceutical Co Ltd | 51.2 | Arzneimittel (Pharmazeutisch) | China | 3.8 Mrd. USD | 18.45 | 137.99 | 3.23 | 2.33 | ▼ -2.27% | ▲ 1.09% | 5.27% | - | - | 16.43% | ▼ -2.37% | 22.69% | ▼ -1.88% | 19.55% | ▲ 2.08% | 9 / 9 | 7,95 | 32-fach | 37 / 100 | −3,6 / 100 | −3,04 |
| Vcanbio Cell & Gene Engineering Corp Ltd | 51.1 | Arzneimittel (Biotechnologie) | China | 1.2 Mrd. USD | 71.05 | 141.44 | 5.95 | 2.22 | ▲ 1.98% | - | - | - | - | 7.82% | ▼ -0.55% | 13.51% | ▼ -0.31% | 18.15% | ▲ 1.44% | 7 / 9 | 4,19 | > 50-fach | 19 / 100 | −3,8 / 100 | −2,75 | |
| Hualan Biological Bacterin Inc. | 50.9 | Arzneimittel (Biotechnologie) | China | 1.5 Mrd. USD | 52.12 | 99.63 | 8.72 | 1.97 | ▼ -13.10% | ▼ -27.68% | 9.21% | - | 3 Jahre | 15.21% | ▼ -4.77% | 15.60% | ▼ -5.95% | 28.89% | ▲ 9.13% | 8 / 9 | 9,52 | > 50-fach | 14 / 100 | −2,6 / 100 | −3,53 |